Nano-X Imaging Ltd. (NASDAQ: NNOX), through its U.S. subsidiary Nanox Impact Inc., has entered into a distribution agreement with Associated X-Ray Imaging Corp. to bring its Nanox.ARC system to the New England region. The partnership is designed to accelerate the deployment of the FDA-cleared, multisource 3D digital tomosynthesis system, which is intended to make advanced imaging more accessible in outpatient and community-based clinical settings.
Under the agreement, Associated X-Ray Imaging will be responsible for marketing, distributing, and supporting the Nanox.ARC. Leveraging its established regional customer relationships and service infrastructure, the company will play a key role in expanding the system's footprint across the six New England states. This move is part of Nanox's broader strategy to grow its U.S. channel partner network and increase the availability of its imaging technology beyond traditional hospital radiology departments.
The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis system designed for ease of use and scalability. Unlike conventional CT scanners, the Nanox.ARC uses multiple X-ray sources to produce 3D images, potentially lowering the cost and size of advanced imaging equipment. This makes it suitable for smaller clinics, urgent care centers, and other community-based settings that may not have the resources to install full-sized CT systems.
According to the company, the expansion into New England is a significant step toward realizing Nanox's vision of "driving the world’s transition to preventive health care." By placing advanced imaging in more accessible locations, Nanox aims to enable earlier detection of diseases and improve patient outcomes. The company's integrated platform includes not only the Nanox.ARC but also AI-based solutions, cloud-based software, teleradiology services, and health IT offerings, all designed to streamline workflows and reduce barriers to adoption.
This distribution agreement follows a series of similar partnerships as Nanox works to build a robust distribution network across the United States. The company's approach is to collaborate with regional distributors who understand local markets and can provide the necessary service and support. Associated X-Ray Imaging, with its expertise in imaging equipment distribution, is expected to facilitate the adoption of the Nanox.ARC in New England's healthcare landscape.
Industry observers note that the move could have significant implications for preventive care. By making affordable 3D imaging more widely available, Nanox hopes to encourage routine screenings and early detection of conditions such as osteoporosis, lung nodules, and cardiovascular disease. The system's design also aims to improve clinical efficiency, allowing healthcare providers to integrate imaging into their practices without substantial infrastructure changes.
Patients in the region may benefit from increased access to advanced diagnostic tools, potentially reducing the need for referrals to larger hospitals and enabling faster diagnosis and treatment. For healthcare providers, the Nanox.ARC offers an opportunity to expand their service offerings and enhance patient care. The system's cloud-based connectivity also supports remote interpretation by radiologists, addressing potential shortages in specialty care.
Nanox's broader ecosystem includes Nanox.AI, which offers AI algorithms to augment CT imaging interpretation; Nanox.CLOUD for secure data management; and access to remote radiology services through USARAD Holdings. These components are intended to create a seamless experience from scan to interpretation, making it easier for clinicians to adopt the technology.
The company has not disclosed the financial terms of the agreement, but such partnerships are part of its growth strategy to commercialize the Nanox.ARC. As Nanox continues to expand its distribution channels, it is positioning itself to compete in the medical imaging market, which is traditionally dominated by larger, more expensive systems from established players.
This development is noteworthy for the healthcare industry as it represents a shift toward more accessible and affordable imaging solutions. If successful, the model could be replicated in other regions, potentially transforming how and where medical imaging is delivered. However, the company faces challenges, including regulatory hurdles, competition, and the need to demonstrate clinical efficacy and cost-effectiveness in real-world settings.
For more information about Nanox and its technologies, visit the company's newsroom at https://ibn.fm/NNOX.
